Clinical Trial Update: A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber [Phase 2]

View source ↗

Summary

This Phase 2 randomized, double-blind, four-way crossover trial assesses the efficacy of Bilastine for Seasonal Allergic Rhinitis; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Bilastine (bilastine)

Snippet

Sponsor: Faes Farma, S.A. | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED